Showing 1 - 10 of 3,436
Persistent link: https://www.econbiz.de/10000455522
Persistent link: https://www.econbiz.de/10001389915
Persistent link: https://www.econbiz.de/10003929591
Persistent link: https://www.econbiz.de/10009551494
Persistent link: https://www.econbiz.de/10001608463
This examination of the economics of the biopharmaceutical industry has 18 chapters by health economists. Part 1 examines the economics of biopharmaceutical innovation. Part 2 examines the market for biopharmaceuticals with chapters on prices and reimbursement in industrialised and developing...
Persistent link: https://www.econbiz.de/10012669706
Persistent link: https://www.econbiz.de/10014472088
Persistent link: https://www.econbiz.de/10010517238
Persistent link: https://www.econbiz.de/10013170079
Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...
Persistent link: https://www.econbiz.de/10012604733